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Abstract
Background: The glycosylation of a great number of molecules, glyco-protein or glycolipids, has
been of interest for decades.
Objective: To compare the expressive patterns of the isoantigenic determinants of histo-blood
groups ABH and Lewis in squamous and simple epithelium and in precursors and cancers of the
cervix.
Methods: A total of 36 lesions and neoplasms (10 LG-SIL, 16 HG-SIL and 10 invasive carcinomas)
have been studied with immunohistochemical techniques, using monoclonal antibodies (MoAb BG1
to BG8) for precursor chains, blood-group ABH and Lewis group Lea, Leb, Lex, and Ley, and four
types of lectins. In addition, we have studied the expression of p53 protein and PCNA, establishing
the rate of proliferation of each lesion. Using PCR techniques, we have also detected part of the
intron of the E6 gene of HPV-16.
Results: In the invasive cervical carcinomas, we observed a loss of expression of the Lex antigen
(p < 0.01). With regard to the progression of the different lesions studied, we found alterations in
the patterns of expression of the antigens of the ABH and Lewis blood groups. There was a
tendency towards a loss of expression and heterogeneous patterns in the more advanced lesions,
as well as over-expression of the Ley antigens. With PCNA, we established a proliferative rate
which tended to be greater in relation to the progression of the cervix neoplasms.
Conclusion: These results indicate that there is a relation between the losses of histo-blood
groups and the progression of the squamous intraepithelial lesions.
Background
The glycosylation of a great number of molecules, glyco-
protein or glycolipids, has been of interest for decades.
Increasing evidence highlights the fact that the carbohy-
drates located in the cellular surface and in the extracelu-
lar matrix play an important role in cellular recognition
and in the organization of tissues and organs, and that the
aberrant expression of carbohydrates is closely related to
certain diseases and to the progression of neoplasms. His-
torically, the functional role of carbohydrates in cellular
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recognition has been the most clearly demonstrable evi-
dence in the development process and in cellular differen-
tiation [1].
Most of the patterns of peripheral/terminal glycosylation
is polymorphic in humans and constitute what is known
as histo-blood groups [2], among which we know the sys-
tems ABO, secretor, Lewis, TTn and P. These antigen deter-
minants have been identified in most human epithelia
[3,4].
Furthermore, in some neoplasms there are frequent alter-
ations of the cellular surface glycoconjugates that, in gen-
eral, have been classified in: (A) incomplete synthesis,
with or without accumulation of precursors, (B) synthesis
of neoglycolipids and (C) organizational changes of the
glycolipids in cellular membranes [5].
They are many studies that relate the alteration of the gly-
coconjugates in different human neoplasms, and the
works dealing with the human urinary tract [6-8], the
digestive tract [9-11], the lungs [12-16], or the genital
organs [17-22] are currently classics.
In addition, several molecular biology techniques arise as
powerful tools that could provide complementary and
valuable information to immunohistochemistry and to
the traditional morphologic diagnosis. In this work we
have combined a immunohistochemical study for the
expression of PCNA (a known proliferative marker-PC-10
clone) and p53 (DO7 clone) with results of amplification
of part of the E6 intron of the HPV-16.
PCNA is a nuclear protein of 36-kd cofactor of the polime-
rase delta detected in interfase cells (G1, S and G2)
[23,24]. Mutations of p53 are the most frecuently
reported in human neoplasms [25]. It has been suggested
that p53 intervenes in the control of the cellular growth in
the critical point among the phase G1 and S playing an
important role of "guardian of the genoma". p53 could
prevent the progression of cells through the cell cycle
when DNA damage has occurred. Thus allows DNA to
repair [26]. With regard to the influence of p53 upon sev-
eral promoters it is considered that p53 could downregu-
late the PCNA RNAm [27]. Its contingent lost of function
would have as consequence an increase of the cellular pro-
liferation. Some authors also have observed that p53
would regulate the transcription of p21 protein which is
known that can inhibit directly the PCNA and other cyc-
lins impeding the synthesis of DNA in case of cellular
damage [28,29]. Finally it is known that a HPV protein
coded in the E6 gene could block and promote the degra-
dation of the wild type of p53 [30,31]. Consequently the
degradation of p53 could decrease p21 releasing its inhi-
bition on PCNA.
We consider that the cervical intraepithelial neoplasms
and carcinomas of the uterine cervix represent an opti-
mum model for the study of the phenotypic alterations in
the progression towards malignancy although, up until
this moment they have been insufficiently explored. For
this, reason, we have studied a total of 36 lesions that cov-
ered a spectrum from cervical metaplasias with and with-
out dysplasia and/or condyloma to the invasive
carcinoma, focusing our attention on the possible altera-
tions of their patterns of glycosylation.
Methods
Patients and lesions included
Samples of cervical lesions and normal adjacent tissues
were surgically obtained from 30 patients (22 total hyster-
ectomies, 8 cone resections and 3 biopsies). Among these
cases we found the following lesions: 19 mature metapla-
sia, 1 immature metaplasia, 1 regenerative epithelium, 9
low grade squamous intraepithelial lesions (6 flat condy-
lomas, 2 condylomas acuminata, and 1 CIN-I), 16 high
grade squamous intraepithelial lesions (3 CIN-II and 13
CIN-III), and 10 invasive carcinomas (9 squamous carci-
nomas and a mixed-carcinoma-epidermoid and adeno-
carcinoma-).
Immunohistochemistry
Five  μm thick sections of formalin-fixed and paraffin-
embedded tumor specimens were cut and deparaffinized
according to routine histological techniques. Serial sec-
tions were stained with primary monoclonal antibodies
(Ortho Diagnostics, Cambridge, Mass) BG1, BG2, BG3,
BG4, BG5, BG6, Bg7, and BG8, reactive to precursor type
1 chains; A group (type 1 and 2 chains); B group (type 2
chains), H-1; Lea (type 1 chain), Leb (type 1 chain), Lex
(type 2 chain), Ley (type 2 chain) determinants, respec-
tively. The working dilution was 1/40 for BG1, BG3, BG5
and BG6, and 1/200 for BG2, BG4, BG7 and BG8, with
incubation of all the primers overnight, followed by the
avidin-biotin complex method.
Similar to previous studies, we included four biotinylated
lectins (Sigma Chemical Co, St Louis, Mo) from Ulex
Europaeus Agglutinin I (UEA I), Sophora Japonica A
(SJA), Dolichos Biflorus (DBA) and Tetragonolobus Pur-
pureas (LTA) with the following blood group specificities:
UEA I, O (H); DBA, A1>A2; SJA, B>A>O (H) and LTA, O
(H) [13,14].
In addition, we used specific monoclonal antibodies NC-
p53-DO7 and NCL-PCNA (Novocastra Laboratories Ltd.,
Newcastle upon Tuyne, UK). Titration of both antibodies
without antigen retrieval was carried out. The best results
were obtained at 1/100. Then an alkaline phosphatase
method chromogen kit (Fast RedTM) was used. The IHC
results were interpreted from each case, evaluating theDiagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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percentage of reacting cells, and the intensity of the stain-
ing on a arbitrary scale from 0 (no staining) to 3 (strong
staining).
The results of the immunohistochemical study were corre-
lated with the amplification or not of the HPV-16 (part of
the intron E6).
Scoring and statistical analysis
For each case we tabulate the findings evaluating the pos-
itive or negative expression, their homogeneity or hetero-
geneity of the stains, the presence of isolated positive cells,
the stain of the cilia of the secretor cells, the stain of the
mucus, and the location of the stain in the epithelium or
in the thickness of the lesion. The results of the immuno-
histochemical study were correlated with the blood group
of the patients, which was obtained from the clinical
charts.
In order to evaluate correlations between the staining
results and clinicopathological variables, the chi-square
test and the exact test of Fisher were applied at a signifi-
cant level of 5%.
DNA extraction and PCR
5–10  μm paraffin sections of each case were cut and
placed in Eppendorf tubes of 1.5 ml. To avoid contamina-
tion, we used disposal knives and the microtome was
washed with absolute ethanol between each block. We
also followed recognized measures in order to prevent
false positives. Sections of formalin-fixed and paraffin-
embedded tumor specimens were used to extract DNA fol-
lowing the protocol described by Shibata et al. (1988)
[32,33].
We dewased in two applications with xylene and absolute
ethanol with a volume of 500 or 1000 μL, depending of
the size of the tissue. Between each application, we centri-
fuged at 12,000 g for 5 min. The tisular sediment was
resuspended in a buffer solution 1/50 of proteinase K (50
mM tris pH 8.5, 1 mM EDTA, Tween 20 at 0.5%) and the
samples were incubated at 37° between 24 to 72 hours,
depending on the cases. DNA was purified by phe-
nol:cloroform followed by ethanol precipitation at -20°
overnight (1/10 volume of 3 M Na-acetate pH 5.2 and 2.5
volumes of pure ethanol with subsequent centrifugation
at full speed for 30 min at 4°C in a bench-top centrifuge).
125 ngm of nucleic acid was used for each 50 μl PCR reac-
tion with Taq DNA Polymerase (Perkin-Elmer Hispania).
Each PCR reaction contained primers for the intron E6 of
the HPV-16 or Beta-globin. Beta-globin was used as a con-
trol gene. The primers had the following sequence: E6
HPV-16 H1+5'ATTAGTGAGTATAGACATTA3'; H2 
-5'GGCTTTTGACAGTTAATACA3' and B-GLOBIN
+5'GGTTGGCCAATCTACTCCCAGG3'; 
-5'GCTCACTCAGTGTGGCAAAG3'. These primers gener-
ated intro E6 and Beta-globin products of 109 and 536
base pairs (bp), respectively. DNA for the HPV-16 was
amplified for 35 cycles on the thermal cycler Perkin-Elmer
Cetus Intruments, Techne. (Table. 1)
The 50 μl DNA amplification reactions for HPV-16 con-
tained 2.5 μl of Buffer I (100 mM Tris-HCL pH 8.3, 500
mM KCl, 15 mM MgCl2, 0.01% (w/v) gelatin. Perkin
Elmer Hispania), 0.15 mM of the dNTP mixture, 15 pmol
of each primer, 2.5 units of Taq polymerase, and 1 μl of
DNA.
Before adding the enzyme, we did a hot start at 95°C for
10 min., followed by 35 cycles: 45 sec. at 96°C for denat-
uralization, 45 sec at 55°C for anneling, and 50 sec. at
72°C for extension, with a step of final extension at 75°C
for 10 min. A second PCR amplification was performed in
the same conditions with 1 μl of the previous product as
a template. The final product was detected in a 3% agarose
gel electrophoresis stained with ethidium bromide. Each
PCR reaction and the following hybridization contained
negative and positive controls. The last one was a CIN-III,
positive for HPV-16 by in situ hybridization and PCR
amplification of the L1 region.
DNA blot transfer and nonradiactive hybridization 
detection
For each sample, we added 120 μl of NaOH 0.5 M to 30
μl of the first amplification product and vortex. After 10
min. at room temperature, we added 150 μl of HN4-ace-
tate 2 M and it was placed in ice. All this volume was trans-
ferred by a filtration process to a nylon membrane
embedded in HN4-acetate 1 M (Boheringer Mannheim
#1209299). After blotting we allowed for drying. The
DNA was cross-linked on the blot membrane on a UV
transilluminator (320 nm for approx. 40 sec.). Subse-
quently, we performed membrane hybridization with dig-
oxigenin-11-dUTP-labeled DNA probe specific for the
Table 1: H1 and H2 primers for VPH 16 intron E6
Subtype HPV primers secuence (5'-3') product PCR
HPV 16 H1: ATT AGT GAG TAT AGA CAT TA 109 bp
H2: GGC TTT TGA CAG TTA ATA CA
HPV-16 E6 p1.- ATGGAACAACATTAGAACAGCAATACAACAAACCGTTGTGDiagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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HPV-16 product amplified, followed by chemiluminis-
cence detection (DIG DNA Labeling and Detection Kit
nonradiactive, Boehringer Mannheim). The probe for
intron E6 of the HPV-16 had the following sequence: p1:
5'atggaacaacattagaacagcaatacaacaaaccgttgtg3'. (Table 1)
The cross-linked membranes were placed in a dry hybrid-
ization tube and prehybridized in a 5 ml hybridization
solution (5 × SSC; 0.1% N-lauryl sarcosine, Na-salt;
0.02% SDS; blocking regeant) during 30 min. at 42°C. We
replaced the hybrization solution with a new 4 ml hybrid-
ization solution preheated at 42°C and added 1 ml of 2
pmol of digoxigenin-11-dUTP labeled DNA probe previ-
ously denatured at 95°C for 5 min. The tubes were placed
in a hybridization for over 16 hours at 42°C, after which
we washed the membranes twice in a rotating tube holder
for 5 min. at room temperature in a solution 2 × SSPE,
0.1% SDS. Then we replaced it with a 3 M TMAC solution
(50 mM Tris pH 8.0, 2 mM EDTA-Na2, and 0.1% SDS),
washing during 15 min at 61°C.
We developed the membranes by chemiluminescent
detection, consisting of the following steps: 1) Wash with
Buffer 1 for 5 min. 2) Wash with Buffer 2 for 30 min. 3)
Incubation with the antibody conjugate anti-digoxigenin
alkaline phosphatase in Buffer 2 for 30 min. 4) Two
washes with Buffer 1 for 15 min. 5) Wash with Buffer 3 for
5 min and 6) Incubation for 5 min with Buffer 3 with
AMPPD (0.1 mg/ml) in a dilution of 1:100 (Buffer 1: 0.1
M maleic acid; 0.15 NaCl; pH 7.5; Buffer 2: 10% Blocking
regeant – Boehringer – in Buffer 1; Buffer 3: 0.1 M tris-
HCl, 0.1 M NaCl, 50 mM MgCl2, pH 9.5).
After withdrawing the excess AMPPD, we placed the mem-
branes in a clean hybridization bag and incubated them at
37°C for 15 min. Finally a film was exposed with the
membranes at room temperature for few seconds.
We also dehybridized the membranes and attempted a
second hybridization at 49°C. The results of this second
hybridization were similar to the first one.
The autoradiographies were scanned and studied by den-
sitometry to generate a curve of grays for each signal. With
the control cases we determined a cut-off line to establish
semiquantitatively the positivity of the test (Figure 1).
Results
The results are summarized in Tables 2 through 6 and in
Figure 2. The eight antigens were expressed in the cyto-
plasmatic membrane in the case of the squamous epithe-
lium, and in the cytoplasm/mucus of the
pseudoglandular lumen, in the case of the simple epithe-
lium. (Table 2, Table 3, Table 4, Table 5, Table 6).
The antigenic expression of the vessel endothelium was
useful as an internal control. Generally, we observed con-
formity among such expressions and the blood group of
the patients that already we knew. As in our previous stud-
ies, we found a stronger staining and a higher number of
positively reacting cells were observed in both normal and
neoplastic tissues, stained with monoclonal antibodies
[14].
As expected, we obtained polymorphic results, given the
expressive variations of the ABH blood group according to
the phenotype of each individual. In addition, within
each group we found individual variations in relation to
the epithelial expression in accordance with their secretor
status. On the other hand, the results for the expression of
the Lewis antigen group were less polymorphic. In table 6
we have classified the cases according to their secretor
character and the expression of the determinant antigens
Lea and Leb.
Normal tissues
The squamous exocervical epithelium as well as the sim-
ple endocervical epithelium expressed the ABH and Le
antigens in the exocervix at the level of the cytoplasmic
membrane and in the endocervix in the cytoplasm and
mucus of the pseudoglands.
The number of positive stained cells for A and B antigens
in the squamous epithelium was higher than the basal
cells and mainly in the middle of the epithelium with a
honeycomb pattern. Invariably, the basal cells were nega-
tive for any antibody. T1-CH and H antigens were nega-
tive in both epithelia, with only occasional expression
areas in 2 of 35 cases and 6 of 35, respectively. However,
in the endocervical epithelium, the ciliary processes were
shown in a higher positive percentage for precursor chains
as well as for the H antigen (16 of 30 and 12 of 31 respec-
tively) (Figure 3).
Lewis antigens, when positive, were generally expressed in
almost the whole thickness of the exocervical epithelium
except for the basal row. The endocervix expressed Lewis
antigens both in the simple epithelium and in the mucus
of the pseudoglandular lights: 15 of 19 positive cases for
Lea were phenotype Le (a+b-)(78.9%), 22 of 29 (75.8%)
were Leb, 22 of 29 Lex, and 27 of 29 Ley.
Both the squamous and simple epithelium expressed the
ABH and Lewis antigens. In the exocervix, the expression
was in the membrane of the cytoplasm and, in the
endocervix, in the cytoplasm and mucus of the pseudog-
lands.Diagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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PCR – Dot-blotting Figure 1
PCR – Dot-blotting. Results of the amplification from intro E6 of the HPV-16 and its specific hibridization.Diagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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Areas of Mature Metaplasia
20 areas of metaplasia were available for the study in the
cervix of 6 and 14 patients bearing LG-SIL and HG-SIL
respectively. Three cases expressed precursor chains T1-
CH and four cases the antigen H. In one of these cases we
observed a heterogeneous expression of both antigens. All
the patients belonging to blood group A and AB expressed
A antigens with the same pattern in their normal tissues
and the areas of metaplasias. The same results were seen
with Lewis antigens. 11 of 16 metaplasias were positive
for Lea and Leb, 11 of 14 expressed Lex and 10 of 13 Ley. In
short, we have not found differences in the glycosylation
patterns when comparing the normal exocervical epithe-
lium with the areas of mature metaplasia.
LG-SIL
We have not observed relevant differences in the exocervix
among the patterns of expression in comparison with the
LG-SIL for the ABO and Lewis blood group antigens.
Precursor chains T1-CH and antigen H were not expressed
by immunohistochemistry, coinciding with the absence
Summary of the staining profiles for anti-blood group monoclonal antibodies of the areas of cervical mature metaplasia, LG-SIL,  HG-SIL and carcinomas Figure 2
Summary of the staining profiles for anti-blood group monoclonal antibodies of the areas of cervical mature metaplasia, LG-SIL, 
HG-SIL and carcinomas. White areas indicate negative staining in the epithelium; dotted areas, positive staining and the locali-
zation of the staining in the epithelium. S: Simple endocervical epithelium, G: Pseudoglandular epithelium, E: Squamous exocer-
vical epithelium, M: Mature metaplasias, LG: LG-SIL, HG:HG-SIL, I: Invasive Carcinomas. Diamon: Mucinous stain. Cilia: Cilia 
stain. Singel dot: ocassional positive cells.
Table 2: Summary of cases included in the study
Blood Group n LG-SIL HG-SIL Carcinoma
A 18 5 8 5
AB 21 1 0
0 16 4 7 5
Total 36 10 16 10Diagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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of expression in the squamous epithelium. We found only
one of 10 cases with occasional expression fields for H1.
A and B antigenic determinants, when expressed in the
LG-SIL, coincided with the blood groups and the pattern
of expression seen in the rest of the epithelium.
When the basal stratum was hyperplasic, this was invaria-
bly negative for the eight antigens with displacement of
the antigenic expression to the most superficial layers.
(Figure 4)
HG-SIL
We have observed an increasing expression of precursor
chains T1-CH and H antigen among the HG-SIL com-
pared with the epithelia and lesions described up until
now. 2 out of 16 cases (12,5%) expressed T1-CH and 5
out of 16 cases (31%) expressed H antigen. The H anti-
genic expression in HG-SIL was higher in the case of
patients belonging to the O group (4/7 of the O group, 1/
8 of the A group). In the patients in the A group with HG-
SIL, we found undoubtful fields of precursor chain expres-
sion.
For the A, B, Lea and Leb antigenic determinants, we found
significant changes of expression compared with the nor-
mal epithelium and the high-degree lesions.
All the cases with A phenotype expressed this antigenic
determinant in high-degree lesions, but with a certain ten-
dency towards a heterogeneous pattern of expression and
weaker stains. 5 out of 9 cases (55,5%), positive for BG2
in normal epithelia, lost their expression in areas of HG-
SIL, some with sharp losses of expression and without a
gradual transition from the positive fields. Concerning the
B antigenic determinant, we found four cases that
expressed this antigen (4/16 25%). Three of these cases
showed heterogeneous patterns. Two were patients from
the O group and another patient belonged to the AB
group. These four cases also expressed the same antigen in
the squamous epithelium and, therefore, we cannot con-
sider them aberrant expressions. Among these cases, we
also observed focal losses of antigenic expression. (Figure
5, Figure 6)
7 out of 11 cases -63%- positive for Lea antigen had
uncompleted losses of expression of this antigen (Figure
7a). Five negative cases for Lea did not express this antigen
in the normal epithelia 3 was Le(a-b-) and 2 Le(a-b+) pheno-
type.
PCNA, p53 and PCR amplification of HPV16 (part of the 
E6 intron)
The PCNA and p53 antigens, when expressed, were seen
in a nuclear pattern. In the normal exocervical epithelium,
PCNA was observed to be positive in the deepest layers,
corresponding with the basal and the first parabasal row.
This expression was intense (++) and concerned 5% of the
cellularity (index of proliferation). Only occasionally did
we find some positive cells for p53.
In the endocervical epithelium, we found neither an
expression for PNCA nor of p53, with the exception of
Table 3: Summary of results of the expression of antigens T1-CH, A, B and H-1.
T1-CH A B H
Simple Epithelium 2[27] 7.4% 11[28] 39.2% 2[29] 6.8% 2[30] 6.6%
Epit. pseudoglandular 16[30] 53.3% 15[29] 51.7% 2[29] 6.8% 12[31] 38.7%
Squamous Epithelium 2[35] 5.7% 20[35] 57.1% 10[36] 27.7% 6[35] 17.1%
Metaplasia 3[20] 15% 12[20] 60% 6[19] 31.5% 4[20] 20%
LG-SIL 0[10] 0% 4[9] 44.4% 6[9] 66.6% 1[9] 11.1%
HG-SIL 2[16] 12.5% 9[16] 56.25% 4[16] 25%% 4[16] 25%
Carcinomas 1[10] 10% 3[10] 30% 6[10] 60% 1[10] 10%
* Fist number: positive expression. Second number among braquest: Total of cases assesed
Table 4: Summary of results of the expression of the antigens Lewis.
Lea Leb Lex Ley
Simple Epithelium 17[23] 73.9% 19[27] 70.3% 18[27] 66.6% 23[26] 88.4%
Epit. pseudoglandular 19[27] 70.3% 20[29] 68.9% 22[29] 75.8% 27[29] 93.1%
Squamous Epithelium 20[33] 60.6% 27[34] 79.4% 26[35] 74.2% 29[35] 82.8%
Metaplasia 11[16] 68.7% 12[16] 75% 11[14] 78.5% 10[13] 76.9%
LG-SIL 4[10] 40% 7[10] 70% 5[10] 50% 7[10] 70%
HG-SIL 11[16] 68.7% 13[16] 81.25% 9[16] 56.2% 11[16] 68.7%
Carcinomas 3[10] 30% 5[10] 50% 2[10] 20% 8[10] 80%
* Fist number: positive expression. Second number among braquest: Total of cases assesedDiagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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some isolated cells. We have not seen differences of
expression for these antigens between the mature meta-
plasias and normal epithelia.
7 to 10 SIL-HG cases had an increased expression of PCNA
with an average proliferative index of 14,7%. This expres-
sion for PCNA was limited to the suprabasal cellular
hyperplasia. On the other hand, we have not observed an
expression for this antigen in those morphologic changes
recognized as related with HPV infection (koilocitos, dis-
queratosis and atypical mitosis). p53, however was found
almost positive in some scattered occasional cells.
Concerning SIL-HG lesions with invasive carcinomas, the
average index of proliferation was significantly higher:
60,35% and 85% in invasive carcinomas (Figure 7b, Fig-
ure 8).
Only in one case of invasive carcinoma was p53 found
over-expressed with 40% positive cell. In this case, PCNA
expression presented a proliferative index of 40%, clearly
inferior to the other cases.
Amplifying by PCR and with subsequent hybridization in
dot-blot, we identified 7 positive cases for the gene E6 of
the HPV-16 of 10 SIL-LG; 7 cases of 15 SIL-HG and 7 out
of 10 invasive carcinomas (21/35 lesions).
Finally, grouping the different cases according to the pos-
itivity or negativity for HPV-16, we have found a higher
proliferative PCNA index in those positive cases for the
virus versus the negative cases (p < 0,05). SIL-LG: 18,28%
proliferative index in HPV16(+) lesions, and 4% in
HPV16(-) lesions. SIL-HG: 69,16% proliferative index in
HPV16(+) lesions, and 61,42% in HPV16(-) lesions. Inva-
sive carcinomas: 91,42% proliferative index in HPV16(+)
lesions, and 62,5% in HPV(-) lesions.
Discussion
We have compared the expression of different isoanti-
genic determinants of ABH and Lewis blood groups in
uterine cervix tissues where we have normal epithelium
and a spectrum of preneoplasias and neoplasias, from
low-grade lesions (morphologic changes of epithelium
related with HPV infection, condylomas and CIN I) to the
invasive carcinoma.
These antigens resisted fixation with saline formaline very
well. In order to compare the results with the monoclonal
antibodies used, we employed different types of lectines:
Ulex Europeaus I,  Lotus Tetragonolobus,  Dolichus Biflorus,
and Shopora Japonica Agglutinins [34].
The results of both methods permitted us to observe a bet-
ter stain definition when we used the MoAbs, although
the patterns of stain tended to be similar in both.
This work stands in the fact that the study of cellular gly-
coconjugates can provide valuable information concern-
ing the events related with neoplastic cellular
transformation. Accordingly, much evidence shows that
in different neoplasias the phenomena of glycosylation of
certain molecules of the cellular membrane show modifi-
cations that could play an important role in relation to
their malignant behavior [35].
The first works in which we began to observe those altera-
tions date from the beginning of the 1930s [36] (Hir-
Table 5: Summary of results of the expression of receptors of lectins.
UEA I SJA DBA LTA
Epit. pseudoglandular 24[27] 88,8% 13[27] 48,1% 13[26] 50% 7[25] 28%
Squamous Epithelium 26[34] 76,4% 21[35] 60% 23[32] 71,8% 17[33] 51,5%
Metaplasia 7[11] 63,6% 8[12] 66,6% 7[14] 50% 3[14] 21,42%
LG-SIL 9[9] 100% 5[9] 55,5% 5[9] 55,5% 4[10] 40%
HG-SIL 9[15] 60% 9[15] 60% 9[15] 60% 8[15] 53,3%
Carcinomas 8[10] 80% 2[10] 20% 8[10] 80% 6[10] 60%
* Fist number: positive expression. Second number among braquest: Total of cases assesed
Table 6: Coexpression of Different Lewis Antigens and ABH Blood Group.
N. Lessions %
Group I (Secretor ABH+, Lewis a, b +) 15 41.60%
Group II (Non secretor ABH-, Lewis a, b +) 13 36.10%
Group III (Secretor ABH+, Lewis a, b -) 25 . 5 0 %
Group IV (Non secretor ABH-, Lewis a, b -) 61 6 . 6 0 %Diagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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schfelt 1929 and Thomsen 1930). Kovarick, Davidsohn
and colleagues 1968, 1969, with immunofluorescence
techniques and mixed cellular reaction agglutination
(MCRA), were the first authors to describe that uterine cer-
vix neoplasias showed losses of expression of specific anti-
gens of ABH blood groups. This fact was interpreted as a
manifestation of the function of dedifferentiation analo-
gous to morphological dedifferentiation and was related,
also from the first studies, to a greater incidence of metas-
tases. The same findings were found in adenocarcinomas
of the gastrointestinal tract, ovary, tumors of transitional
cells originating in the urinary tract, and in squamous car-
cinomas of the skin, tongue and larynx [37,17].
Likewise, since then it was recognized that in the
sequence: metaplasia, dysplasia and carcinoma in situ of
the cervix, a good model is reproduced in which the alter-
ations of the isoantigen ABH expression can be followed.
Several authors have confirmed the findings of Kovarik
and Davidsohn in the cervix [18,36,38]. Bonfiglio and
colleagues were the first in publishing a work using, in
addition to the immunofluorescence technique, an
immunoperoxidase technique for the determination of
the A and B isoantigens [39].
Mambo observed that 33% of the condyloma acumina-
tum of the uterine cervix had complete losses of some of
the blood group ABH isoantigens, and partial losses in
47% [40]. We could not confirm those findings, although
the number of cases in our study is smaller and our objec-
tive was not centred on low-grade lesions.
The pattern of expression of the ABH antigens in the mid-
dle of the epithelium that we have observed was previ-
ously described by Stubbe Teglbjang and colleagues using
immunofluorescence. These authors found that the
exocervical epithelium had a progressive pattern in the
Detail of the ciliary expression of MoAb BG1 (T1-CH) Figure 3
Detail of the ciliary expression of MoAb BG1 (T1-CH).
Up: Squamous intraepithelial lesion of low grade (Condy- loma) Figure 4
Up: Squamous intraepithelial lesion of low grade (Condy-
loma). Expression of MoAb BG6 (Leb) over the basal layer. 
Down: Squamous intraepithelial lesion of low degree (Flat 
condyloma). Uniform expression of MoAb BG2 (A) over the 
basal layer that is negative.Diagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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expression of the blood group isoantigens, with expres-
sions in the basal and parabasal cells of N-Acetyllactos-
amine, of the antigen H in the parabasal and in the cells
of the low spinosus stratum, and of the A antigen in cells
of the high spinous stratum. They also observed that the
premalignant and malignant lesions had irregular
decreases in the content of the antigens A and H, with an
almost complete loss of them, and precursor chain accu-
mulation [41].
Following a technique using immunohistochemistry with
the avidin-biotin complex, we have not been able to
observe a clear accumulation of precursor chains although
we have found significant results in the loss of expression
of the A antigen.
To and colleagues have described that the expression of
the blood group antigens, in combination with the depth
of the tumoral invasion, could serve as a predictor of sur-
vival in cervical carcinoma [42]. In the same direction,
Sakamoto and colleagues observed a greater frequency of
complete loss of the antigen H in small cell carcinomas,
which have also a worse survival to the two years, versus
to the squamous carcinomas with a better survival [43].
The sum of this evidence has led to us to study, after our
experience with the respiratory mucosa [13,14], the alter-
ations of the glycosylation in different cervical lesions.
Our findings are very similar to those from our previous
studies, leading us to believe that these alterations could
be a phenomenon common in different tumors with dif-
ferent etiological implications.
Our work, unlike its precedents, is complemented with
the use of lectins, a tool that has served to control the
results by means of immunohistochemistry to discard
Up: CIN I with morphologic changes related to infection by  HPV Figure 5
Up: CIN I with morphologic changes related to infection by 
HPV. Absence of expression of the MoAb BG2 (A) in the 
basal and parabasal layers, and expressión of this one Ab in 
the middle of epitelium. Down: Squamous intrapithelial lesion 
of the high grade. Area of heterogenous expression of MoAb 
BG6 (Leb) in a CIN III. Focal losses of expression.
Up: Extension of CIN III in the pseudoglands that show a cel- lularity with heterogenous expression and diminution of the  expression of MoAb BG2 (Blood Group A) Figure 6
Up: Extension of CIN III in the pseudoglands that show a cel-
lularity with heterogenous expression and diminution of the 
expression of MoAb BG2 (Blood Group A). Down: Detail of 
the same lesion where an abrupt cut of expression of MoAb 
BG2 is observed. In addition the expression of this Ab in the 
endothelial lining of small capillares can be appreciated like 
internal control.Diagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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possible artefacts motivated by the fixation or the differ-
ent processing of the tissues.
On the other hand, HPV infection has been strongly
related to cancers of the lower female genital tract, penis,
larynx, lungs and anus. It is known that the subtypes 16,
18, 45 and 56 in cervical lesions are related to a greater rel-
ative risk of developing invasive carcinomas [44,45].
Some papers point out that the percentage of PCNA posi-
tive proliferation cells is significantly higher in premalig-
nant and malignant lesions of the uterine cervix than in
nonneoplastic lesions [46].
To investigate the possible differential expression of
PCNA in negative and positive lessions of the cervix for E6
HPV-16 lesions, we have studied, using immunohisto-
chemistry and PCR, different cases from flat condylomas
to invasive caricinomas. We also inquired into the overex-
pression of p53 in order to explain the cases with a possi-
ble alteration of this tumor supressor gen.
We did not find a significant expression of p53 as other
authors have reported [47]. Only occasional basal or para-
basal nucleus could be seen as positive with the DO-7
MoAB clone. However PCNA was expressed more progres-
sively from a lower grade to the higher degrade and inva-
sive carcinomas. Our results are consistent with the
observations that the cell proliferating index as detected
immunohistochemically using PCNA may be a useful
parameter to indicate the degree of CIN. In addition, we
found in our study a higher PCNA proliferation index in
CIN III and invasive carcinomas of cervix positive for
HPV-16 versus the cases that are negative for this type of
virus.
Conclusion
To sum up, the results and conclusions of this paper are as
follows: (1) In the invasive cervical carcinomas, we
observed a loss of expression of the Lex antigen (p < 0.01).
(2) Almost significant differences were observed when
comparing the expression of Lea, and blood group A anti-
gens in squamous epithelium and invasive carcinomas (p
< 0.1). (3) With regard to the progression of the different
lesions studied, we found alterations in the patterns of
expression of the antigens of the ABH and Lewis blood
groups. There was a tendency towards loss of expression
and heterogeneous patterns in the more advanced lesions,
and also overexpression of the Ley antigens. (4) With
PCNA, we established a proliferative rate which tended to
be greater in relation to the progression of the cervix neo-
plasms. (5) We found only one positive case of MoAb
DO-7 protein p53 in the invasive carcinomas that pro-
Up: Pseudoglandular endocervical with positive expression  for BG5 (Lea) and CIN III invasion with lossess of peripheral  expression of the same Ab Figure 7
Up: Pseudoglandular endocervical with positive expression 
for BG5 (Lea) and CIN III invasion with lossess of peripheral 
expression of the same Ab. Down: The same cut with posi-
tive expression for PCNA in a 85% of cellularity, preferably 
in the periphery where the BG5 (Lea) was not expressed.
Expression of PCNA in a 100% of the cellularity of an invad- ing squamous carcinoma Figure 8
Expression of PCNA in a 100% of the cellularity of an invad-
ing squamous carcinoma.Diagnostic Pathology 2008, 3:38 http://www.diagnosticpathology.org/content/3/1/38
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duced negative results for the HPV-16 virus. (6) Using
PCR techniques, we had a 60% detection rate of part of
the intron E6 of the HPV-16 in all the lesions included in
the study.
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